C. Grosse-Thie

发表

Motivation and preferences of cancer patients to perform physical training.

M. Behrens, H. Murua Escobar, C. Junghanss, 2020, European journal of cancer care.

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.

C. Hemmelmann, J. Finke, T. Luft, 2019, The Lancet. Haematology.

Longitudinal observation of anxiety and depression among palliative care cancer patients.

G. Fuellen, G. Kundt, C. Junghanss, 2021, Annals of palliative medicine.

Preclinical Head and Neck Squamous Cell Carcinoma Models for Combined Targeted Therapy Approaches

H. Lemcke, C. Junghanss, C. Grosse-Thie, 2022, Cancers.

Long-term survivor of metastatic squamous-cell head and neck carcinoma with occult primary after cetuximab-based chemotherapy: A case report

C. Junghanss, C. Grosse-Thie, C. Maletzki, 2021, World journal of clinical cases.

sCD14 in Bronchoalveolar Lavage 18, 42 and 162 Hours After Segmental Allergen Provocation

J. Virchow, C. Grosse-Thie, P. Julius, 2010, Scandinavian journal of immunology.

The Individual Effects of Cyclin-Dependent Kinase Inhibitors on Head and Neck Cancer Cells—A Systematic Analysis

H. Lemcke, C. Junghanss, C. Grosse-Thie, 2021, Cancers.

A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharynge

H. Sudhoff, M. Görner, N. Rotter, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial

T. Gauler, R. Fietkau, P. Martus, 2021, Oncology Research and Treatment.

A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Locally Recurrent Head and Neck Cancer

C. Belka, R. Fietkau, P. Balermpas, 2021, Cancers.

Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer

C. Belka, R. Fietkau, P. Balermpas, 2020, BMC Cancer.

Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108).

Harry W. Lindeman, T. Gauler, A. Dietz, 2019, European journal of cancer.

AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial

A. Hüttmann, M. Dietlein, C. Kobe, 2022, Leukemia & lymphoma.

Establishment and characterization of patient-derived head and neck cancer models from surgical specimens and endoscopic biopsies

C. Junghanss, C. Grosse-Thie, A. Zimpfer, 2021, Journal of Experimental & Clinical Cancer Research.

Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology?

C. Junghanss, C. Grosse-Thie, C. Riess, 2020, Cancer and Metastasis Reviews.

Genetic Mutations in a Patient with Chronic Myeloid Leukemia Showing Blast Crisis 10 Years After Presentation

H. Glaeser, C. Junghanss, C. Grosse-Thie, 2018, AntiCancer Research.

Feasibility and Effects of a Supervised Exercise Program Suitable for Independent Training at Home on Physical Function and Quality of Life in Head and Neck Cancer Patients: A Pilot Study

M. Behrens, C. Junghanss, S. Felser, 2020, Integrative cancer therapies.

Questionnaires measuring quality of life and satisfaction of patients and their relatives in a palliative care setting-German translation of FAMCARE-2 and the palliative care subscale of FACIT-Pal.

D. Cella, J. Panse, C. Junghanss, 2018, Annals of palliative medicine.

Ultradeep targeted sequencing reveals low allele frequencies of somatic JAK2 and MPL variants in patients with abdominal vein thromboses: results of an ongoing prospective prevalence study in Mecklenburg-West Pomerania

H. Murua Escobar, C. Junghanss, L. Henze, 2020, Biomarker research.

Abdominal venous thromboses: detection of the JAK2 p.V617F mutation by next-generation ultradeep sequencing—A prevalence study of patients in Mecklenburg-West Pomerania (2017–2021)

L. Henze, S. Felser, C. Grosse-Thie, 2024, Frontiers in medicine.

Feasibility of individualized home exercise programs for patients with head and neck cancer–study protocol and first results of a multicentre single-arm intervention trial (OSHO #94)

S. Felser, C. Grosse-Thie, U. Kriesen, 2024, medRxiv.